Constellation Brands Tops Q2 2027 Profit Forecast With $3.74 EPS

Constellation Brands (STZ) reported Q2 2027 EPS of $3.74, beating estimates by 5.4%, with revenue of $2.63B, up 3.5% YoY. The Beer segment drove growth, with revenue up 5.0% YoY. The company raised FY 2027 EPS guidance to $11.20-$11.90. Shares rose 1.3% to $117.26. Analysts are mostly bullish, with 15 buy ratings.

Original reporting
Published Oct 7, 2026, 2:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 4:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Constellation Brands Tops Q2 2027 Profit Forecast With $3.74 EPS — source image
Decision brief

The 30-second read

$STZBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest near‑term upside, but investors should monitor cost trends and competitive dynamics.

02

Market read

The report provides fresh, material information that can influence trading decisions on STZ today.

03

What to watch

Potential headwinds from input cost inflation or regulatory changes in the alcohol sector.

Relevance 8/10Novelty 9/10Timing: pre‑market today

Background

Constellation Brands is a leading beverage alcohol company with major beer brands, reporting its Q2 2027 results.

Company-level read

Ticker impact

$STZBullishHigh confidence
Context

Constellation Brands reported Q2 2027 EPS of $3.74 beating estimates and raised FY 2027 guidance to $11.20‑$11.90.

Expected impact

likely upward pressure as investors price in the beat and higher guidance

Evidence & confidence

The beat exceeds consensus by 5.4% and guidance is above prior expectations, driving a 1.3% pre‑market rise.

Market effects

Strong beer segment performance may lift other beverage and consumer discretionary stocks.

Positive earnings from a U.S. consumer staple could boost broader U.S. market sentiment.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If guidance falls short of analyst expectations later, the stock could face a pull‑back despite the beat.

Key entities

  • Constellation Brands, Inc.

    Issuer of the earnings report.

Related articles

$STZMedAI 8/10

Constellation Brands Agrees to Buy SpikedAde for Up to $353 Million

Constellation Brands (STZ) agreed to buy SpikedAde for up to $353M, entering the 'hard hydration' alcohol segment. The deal follows Q2 results showing beer sales growth but softer retail demand. CEO Nick Fink aims to diversify, though past acquisitions have underperformed. Analysts note the deal's manageable size but caution about the category's long-term potential.

$STZHighAI 8/10

Constellation Brands: Q2 Revenue Rises 6% To $2.63 Billion As Beer And Wine And Spirits Sales Grow

Constellation Brands reported Q2 fiscal 2027 net sales of $2.63B, up 6% YoY. Beer sales rose 5% to $2.47B, while Wine and Spirits sales increased 17% to $159.4M. Operating income fell 8% to $805M, but EPS rose 25% to $3.32. The company acquired SpikedAde for $75M, with up to $278M in contingent payments. Constellation updated its fiscal 2027 EPS guidance to $11.85-$12.55 and declared a $1.03 quarterly dividend.

$LWLow

Earnings market review: beats fall short as guidance and costs drive reactions

Lamb Weston (LW) and Constellation Brands (STZ) reported earnings beats but faced mixed reactions due to guidance and cost pressures. PepsiCo (PEP) and Delta Air Lines (DAL) also reported, with DAL missing EPS estimates. Analysts note that estimate revisions, not just beats, are driving market reactions. The macro backdrop includes high yields and expensive oil, impacting earnings expectations.